Edwards Lifesciences (EW) Net Income Growth (3y) (2012 - 2025)
Edwards Lifesciences (EW) Net Income Growth (3y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 280.49% |
| 10 | Steris | 21.52 Bn | 21.08 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -48.74% |
| Sep 30, 2025 | -26.11% |
| Jun 30, 2025 | -26.22% |
| Mar 31, 2025 | -26.40% |
| Dec 31, 2024 | -51.06% |
| Sep 30, 2024 | 99.67% |
| Jun 30, 2024 | -87.31% |
| Mar 31, 2024 | -57.42% |
| Dec 31, 2023 | -50.92% |
| Sep 30, 2023 | -46.86% |
| Jun 30, 2023 | 34.70% |
| Mar 31, 2023 | -49.54% |
| Dec 31, 2022 | -10.56% |
| Sep 30, 2022 | 7.73% |
| Jun 30, 2022 | 18.81% |
| Mar 31, 2022 | 14.37% |
| Dec 31, 2021 | 263.17% |
| Sep 30, 2021 | 14.61% |
| Jun 30, 2021 | 20.08% |
| Mar 31, 2021 | 17.85% |